JPS5988476A - 新規なｎ−（５−アミノメチル−２−オキサゾリン−２−イル）−ｎ′−フエニルウレア、その製法及び治療への適用 - Google Patents

新規なｎ−（５−アミノメチル−２−オキサゾリン−２−イル）−ｎ′−フエニルウレア、その製法及び治療への適用

Info

Publication number
JPS5988476A
JPS5988476A JP58185794A JP18579483A JPS5988476A JP S5988476 A JPS5988476 A JP S5988476A JP 58185794 A JP58185794 A JP 58185794A JP 18579483 A JP18579483 A JP 18579483A JP S5988476 A JPS5988476 A JP S5988476A
Authority
JP
Japan
Prior art keywords
phenyl
product
novel
protons
product according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58185794A
Other languages
English (en)
Japanese (ja)
Inventor
マリ−−エレ−ヌ・クリユゼ
クロ−ド・フニウ
クリスチヤン・ジヤリ−
ジゼル・プラ
アンリ・ポンタニエ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial SA filed Critical Cortial SA
Publication of JPS5988476A publication Critical patent/JPS5988476A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP58185794A 1982-10-05 1983-10-04 新規なｎ−（５−アミノメチル−２−オキサゾリン−２−イル）−ｎ′−フエニルウレア、その製法及び治療への適用 Pending JPS5988476A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8216783A FR2533923A1 (fr) 1982-10-05 1982-10-05 Nouvelles n-(aminomethyl-5 oxazolin-2 yl-2) n'-phenylurees, leur methode de preparation ainsi que leur application therapeutique
FR8216783 1982-10-05
FR8313013 1983-08-04

Publications (1)

Publication Number Publication Date
JPS5988476A true JPS5988476A (ja) 1984-05-22

Family

ID=9278039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58185794A Pending JPS5988476A (ja) 1982-10-05 1983-10-04 新規なｎ−（５−アミノメチル−２−オキサゾリン−２−イル）−ｎ′−フエニルウレア、その製法及び治療への適用

Country Status (3)

Country Link
JP (1) JPS5988476A (fr)
CA (1) CA1219875A (fr)
FR (1) FR2533923A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6413075U (fr) * 1987-07-13 1989-01-24
JP2016517411A (ja) * 2013-03-14 2016-06-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ グリコシダーゼ阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302662B (fr) * 1971-02-04
FR3206M (fr) * 1960-10-13 1965-03-22 Albert Ag Chem Werke Dérivés de la 5-méthyl-oxazolidine.
US3481950A (en) * 1967-06-28 1969-12-02 Abbott Lab Substituted (4 - oxo-2-oxazolidinylidene) urea derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6413075U (fr) * 1987-07-13 1989-01-24
JP2016517411A (ja) * 2013-03-14 2016-06-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ グリコシダーゼ阻害剤

Also Published As

Publication number Publication date
FR2533923A1 (fr) 1984-04-06
FR2533923B1 (fr) 1984-12-21
CA1219875A (fr) 1987-03-31

Similar Documents

Publication Publication Date Title
US3485847A (en) 4-aryl-1,4-dihydropyridines
JPS62167752A (ja) フエニルアセトニトリル誘導体その医薬組成物および哺乳動物におけるカルシウムイオンきつ抗作用または抗高圧作用促進方法
FR2477148A1 (fr) Nouvelles 2 (1h)-pyridones, leur preparation et leur application comme medicaments
GB2243833A (en) 2-substituted 4-amino-5-chloro-n-[2-(diethylamino)ethyl]-benzamides
JPS5988476A (ja) 新規なｎ−（５−アミノメチル−２−オキサゾリン−２−イル）−ｎ′−フエニルウレア、その製法及び治療への適用
EP0105821B1 (fr) Nouvelles N-(aminométhyl-5-oxazolin-2-yl-2)N'-phénylurées
FR2460294A1 (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
US3772276A (en) As-triazines
CA1129875A (fr) Derives de chromone
JPH08500111A (ja) カリウムチャンネルブロッカーとしてのシアノグアニジン類
CH497433A (fr) Procédé de préparation de nouveaux dérivés des benzimidazoles
CA1263391A (fr) N-carboxyalcoyl-2 oxo-3 diaryl 5-6 triazines utiles en therapeutique
JPS5826871A (ja) 新規ヘテロアリールオキシプロパノールアミンおよびその製法
JPH0352875A (ja) ４，５，６，７，―四置換ベンゾオキサゾロン類
US3884954A (en) 12-Cyano-5,6,7,12-tetrahydrodibenzo{8 a,d{9 cyclooctenes
US3420839A (en) Aminomethyl pyrazolone derivatives of nicotinamide
US3499004A (en) Thiophene-2-aldehyde-thiosemicarbazone
CH629194A5 (fr) Amino aryl triazines-1,2,4 utilisables dans le traitement d'algies diverses.
US3376194A (en) Method of treating hypertension employing selected thioureas
JPS6350346B2 (fr)
US3098008A (en) Method for treatment of dermatological disorders
US3907999A (en) Substituted dibenzocyclooctene compositions
FR2545489A1 (fr) Nouveaux derives n-acyles du 2-oxo-thiazolidine-4-carboxylate de 4-aminophenyle, leur preparation et leur utilisation comme medicaments
JPS5940132B2 (ja) ベ−タ交感神経遮断剤
US3124589A (en) Certain z-alkylamino polymethylene